Background
==========

The application of microarray techniques has provided insights into the multi-dimensional molecular nature of complex neuropsychiatric disorders. Studies have highlighted the value of using peripheral tissue targets \[[@B1],[@B2]\], an approach based on the functional integration of neural-, endocrine- and immune-systems \[[@B3]\]. Regulatory exchanges between components of these systems provide a foundation for using peripheral tissue targets as indicators of neuropsychiatric states.

One of the earliest demonstrations that gene expression changes in peripheral blood mononucleoctyes (PBMCs) reflected disease states in the brain, was based on a rat model, where acute neural assaults resulted in gene expression changes in PBMCs within 24 hours \[[@B4]\]. Recent studies have focused on human neuropsychiatric disorders with more subtle disruptions in neurophysiology. Segman *et al*\[[@B1]\] were able to predict the onset and progression of post-traumatic stress disorder (PTSD), in recently traumatised patients. Similarly, Tsuang *et al*\[[@B2]\] showed that the microarray analysis of peripheral blood samples discriminated between patients clinically diagnosed with schizophrenia or bipolar disorder and healthy controls. Nevertheless, it remains to be established whether gene expression changes in peripheral tissue targets are paralleled by specific transcriptional alterations in neural tissues \[[@B1]\].

We have used the model of maternal separation, which is known to induce long term alterations in neurophysiology and stress-related behaviours in adult rodents \[[@B5],[@B6]\] to investigate i) whether parallel changes occur in gene expression in three brain regions (the prefrontal cortex, hippocampus, and hypothalamus) and PBMCs and ii) whether gene expression changes in PBMCs could be used to predict the animal treatment group.

Methods
=======

Animals and treatment
---------------------

Maternal separation was carried out on C57BL/6 mice as previously described \[[@B6]\] with some modifications. Briefly, MS litters were separated from dams for 3 h a day, starting at 12 h 00 and ending at 15 h 00, from postnatal day (PND) 1 to 14. SH animals underwent brief daily handling. All subsequent procedures were carried out using males only, as the consequences of separation are gender specific \[[@B6]\].

Acute restraint stress, sacrifice, blood collection and brain dissections
-------------------------------------------------------------------------

Mice (N~MS~= 30, N~SH~= 30) were subjected to 10 min of acute restraint stress and allowed to recover for 20 min prior to sacrifice. Restraint stress was chosen as a means of acutely activating the Hypothalamic-Pituitary-Adrenal (HPA) axis (HPAA), which allowed for an assessment of possible differences in plasma corticosterone profiles (van Heerden et al, submitted manuscript). All mice were sacrificed, by means of cervical dislocation, immediately followed by decapitation and collection of trunk blood. Neural tissues: the (1) prefrontal cortex (PFC), (2) hippocampus (Hic) and (3) hypothalamus (HYP) were immediately dissected and submerged in RNALater^®^(Qiagen Inc., USA).

Microarray processing and data analysis
---------------------------------------

Fifty-five samples, 15× PFC (8× MS and 7× SH), 10× Hic and 10× Hyp (5× MS and 5× SH, each and 20× PBMC (10× MS and 10× SH) were used for microarray processing, with a two-colour common reference design. Samples were matched, so that 10 individuals (5× MS and 5× SH) were completely represented in all tissues. A common reference pool was constructed by combining equal amounts (0.75 μg) of PFC and Hic RNA from both groups. Commercial pre-spotted, full mouse genome, microarray slides (OpArray™) were sourced from Operon (Operon Biotechnologies, Germany). Full details of RNA labelling, microarray hybridization, image capture and microarray data processing are given in Additional file [1](#S1){ref-type="supplementary-material"}: Supplementary Methods. Microarray data are available in the ArrayExpress database <http://www.ebi.ac.uk/arrayexpress> under accession number E-MEXP-2101.

Data normalization was done in R, using the Limma package \[[@B7]\]. Pre-processing and removal of batch effects were done using GEPAS <http://www.gepas.org> and ASCA-genes \[[@B8]\] respectively. Differentially expressed genes were identified using a concordance strategy \[[@B9]\], based on overlap between three statistically divergent approaches. Genes that had a P-value \< 0.05, using both the Info statistic, from the ScoreGenes software package <http://www.cs.huji.ac.il/labs/compbio/scoregenes/>, and the Tusher *et al*\[[@B10]\] Significance Analysis of Microarrays (SAM) implementation in the T-Rex module of GEPAS <http://www.gepas.org>, in addition to an absolute fold-change \> 1.2 (where fold change is defined as the fold difference between MS and SH), were considered to be differentially expressed (DE).

All data clustering was done in the Tigr MultiExperiment Viewer V4.1 (TMEV, <http://www.tm4.org>) using a Pearson correlation metric with average linkage. Functional enrichment of GO terms within differentially expressed gene sets was evaluated using Blast2GO \[[@B11]\]. Gene set enrichment analysis on lists ordered according to SAM statistics was done using FatiScan <http://www.babelomics.org>\[[@B12]\]. The PFC and Hyp lists were evaluated using 50 partitions, the PBMC list using 55 partitions and the Hic list using 60 partitions.

The efficiency of PBMC gene expression profiles at predicting the treatment class of samples (i.e. MS or SH) was evaluated with the Prophet module in GEPAS <http://www.gepas.org>\[[@B13]\] using both the K-nearest neighbour (KNN) and Support Vector machine (SVM) algorithm options. Leave-one-out cross validation was used to counter selection bias whilst simultaneously assessing prediction efficacy.

Results and Discussion
======================

Microarray data comparing the response of control and MS adult mice to stress was used to investigate the presence of a functional link between gene expression changes in the brain and PBMCs. In the first instance data was analysed to characterise the transcriptional response of three brain regions, the prefrontal cortex, the hippocampus and hypothalamus to stress, and to investigate whether a co-ordinated change in glutamatergic and GABAergic systems occurred in MS mice. Corresponding differences in gene expression in PBMCs of MS mice compared to control mice were also identified. Importantly, these differences could be used to predict the treatment status of mice.

Microarray analysis
-------------------

After normalization, replicate merging, removal of flagged features and imputation, the number of genes expressed in each tissue was: (1) PFC, 15 760; (2) Hic, 17 344; (3) Hyp, 15 794 and (4) PBMC, 13 306.

MS produced gene expression differences in all tissues
------------------------------------------------------

Differentially expressed (DE) genes were identified in all tissues (Figure [1A-D](#F1){ref-type="fig"}). A summary of all DE genes is provided in \[see Additional file [2](#S2){ref-type="supplementary-material"} Table S2\], \[see Additional file [3](#S3){ref-type="supplementary-material"} Table S3\], \[see Additional file [4](#S4){ref-type="supplementary-material"} Table S4\], and \[see Additional file [5](#S5){ref-type="supplementary-material"} Table S5\]. The unsupervised hierarchical sample clustering of differentially expressed genes, produced clear group (MS or SH) separations within all tissues (Figure [1E-H](#F1){ref-type="fig"}). No single gene was differentially expressed across all tissues.

![**Differential gene expression results**. Venn diagrams show the overlap between different gene selection criteria (Info and SAM P \< 0.05 and Fold difference \> 1.2) for (A) PBMC, (B) pFC, (C) Hic and (D) Hyp. This gene selection strategy significantly reduced the number of genes identified as DE by any one single criterion. Also shown are the false colour sample profiles of hierarchically clustered differentially expressed genes for (E) PBMC samples \[347 over- and 71 under-expressed\], and neural tissues (F) pFC \[66 over- and 88 under-expressed\], (G) Hic \[71 over- and 75 under-expressed\] and (H) Hyp \[69 over- and 81 under-expressed\]. The selected genes produce a clear separation between MS and SH samples. Genes more highly expressed in MS samples are at the top and those more highly expressed in SH samples at the bottom. P = PBMC; F = pFC.](1756-0500-2-195-1){#F1}

Gene set enrichment analysis revealed significant functional themes
-------------------------------------------------------------------

The FatiScan analysis revealed the significant enrichment of functional terms, in all tissues (Figure [2](#F2){ref-type="fig"} and Figure [3](#F3){ref-type="fig"}). In PBMC samples (Figure [3B](#F3){ref-type="fig"}), over-expressed terms could be grouped, generally, into signalling- (GO:0004872, GO:0051606, GO:0005887, GO:0007165, GO:0007154), immune- (GO:0006955, GO:0006952, GO:0005856, GO:0007275) and, interestingly, neurologically-related (GO:0008188, GO:0050877) classes. On the other hand, under-expressed terms all displayed a metabolic theme, with terms related to RNA and protein processing (GO:0003735, GO:0016070, GO:0044267, GO:0009058, GO:0009059, GO:0015031, GO:0006412, GO:0005840, GO:0003676 and GO:0043021) and energy metabolism (GO:0005739, GO:0051187 and GO:0006099). These results suggest a functional shift in the immune system in PBMCs in MS mice, characterised by the coordinated down-regulation of energy requiring processes, such as protein synthesis and transport. This functional shift might reflect the well characterised mobilisation of energy and inhibition of further storage in response to stress \[[@B14]\].

![**FatiScan gene set enrichment results**. Shown are significant co-ordinately expressed GO terms within whole gene sets for (A) PFC and (B) Hic. The normalized percentage of genes annotated with a specific term is indicated for each group. Red indicates coordinated over-expression in MS group and Blue coordinated over-expression SH group (or under-expression in MS group). Colour intensity denotes how strongly a term is over- or under-expressed.](1756-0500-2-195-2){#F2}

![**FatiScan gene set enrichment results**. Shown are significant co-ordinately expressed GO terms within whole gene sets for (A) Hyp and (B) PBMC. The normalized percentage of genes annotated with a specific term is indicated for each group. Red indicates coordinated over-expression in MS group and Blue coordinated over-expression SH group (or under-expression in MS group). Colour intensity denotes how strongly a term is over- or under-expressed.](1756-0500-2-195-3){#F3}

Response of the glutamergic and GABergic systems in neural tissues after stress
-------------------------------------------------------------------------------

DE genes and enriched functional terms from the PFC datasets highlighted the importance of the glutamatergic and GABAergic systems in the stress-related response of the MS mice. These two neurotransmitter systems constitute the major stimulatory (glutamate) and inhibitory (GABA) mechanisms of neurotransmission, and work counteractively to ensure optimal neuronal activity after stress \[[@B15]\]. Glutamatergic signalling was enhanced in MS mice possibly as a consequence of deficiencies in GABAergic mediated inhibitory mechanisms.

DE genes whose products are involved in the modulation of glutamatergic and GABAergic signalling included *P2yr4*and *Npvf*(Figure [4](#F4){ref-type="fig"}). The activation of P2yr4 positively regulates glutamate release \[[@B16]\], whereas Npvf is an important inhibitor of GABAergic neurotransmission \[[@B17]\]. The over-expression of both these genes in the MS PFC tissue, points to a hyperactive glutamatergic system. Supporting this observation is the under-expression of *Myo6*in the MS samples. Myo6 is crucial for the efficient endocytosis of postsynaptic glutamate receptors, with deficiencies resulting in increased excitatory neurotransmission \[[@B18]\]. *Htr3a*was also under-expressed in MS samples. This receptor is strongly associated with GABAergic neurons and interneurons which activate the GABA mediated inhibitory neurotransmission in the prefrontal cortex \[[@B19]\]. The co-ordinated under-expression of both pre- and post-synaptic component GO terms further supports the hypothesis of a hyperglutamatergic state in the PFC of MS mice (Figure [4](#F4){ref-type="fig"}). Specifically, genes supporting depletion of postsynaptic components in MS mice included three GABA~A~receptors (GABA~A~alpha-1 and -3, and GABA~A~gamma-3) (Figure [4](#F4){ref-type="fig"}); such receptors mediate inhibition of neurotransmission with disruptions resulting in enhanced anxiety \[[@B20]\]. Genes supporting functional depletion of presynaptic components included two metabotropic glutamate receptors, *mGluR3*and *mGluR7*(Figure [4](#F4){ref-type="fig"}). These receptors participate in negative feedback mechanisms that inhibit presynaptic glutamate release. Results from the hippocampal gene expression dataset extend these observations, with the over-representation, in MS samples, of genes involved in ionotropic glutamate signalling (Figure [4](#F4){ref-type="fig"}). Although this hyperglutamatergic theme was not readily apparent in either the DE genes or functionally enriched terms of the hypothalamus dataset, under-expression of cortistatin may be relevant insofar as cortistatin signalling inhibits glutamate induced responses in hypothalamus \[[@B21]\] (Figure [4](#F4){ref-type="fig"}).

![**Schematic summary of neural gene expression results in support of a stress-related hyperglutamatergic state in MS brain samples**. Such a hyperglutamaterigc state could potentially result in elevated stress-induced corticosterone responses. Red indicates over-expression and blue under-expression, in MS samples, respectively. An asterisk indicates genes or functional classes that were found to be regulated in a coordinated manner. Glu = Glutamate, (+) indicates increased signalling activity, (-) indicates decreased signalling/acitivity.](1756-0500-2-195-4){#F4}

These findings are consistent with the central role of glutamate in the stress-response, in structures such as PFC and hippocampus. Stressors such as acute restraint have been shown to produce dramatic and rapid increases in glutamate levels primarily in the PFC, which ultimately culminates in HPAA activation and glucocorticoid secretion. In addition, the hippocampus is a major site of stress-associated glutamate action. The mechanisms which regulate glutamate action and release within this region function downstream of prefrontal cortical processes, constituting a secondary stress-response phase, which, unlike the PFC, is sensitive to neuroendocrine modulation \[[@B22]\]. The glutamatergic signature found here in both the PFC and hippocampus is therefore consistent with previous work.

Functional significance of gene expression changes in PBMC tissues
------------------------------------------------------------------

A large number of genes (418) were found to be differentially expressed between MS and SH individuals and included several genes whose products are important modulators of immune system function. Examples include *Foxp3*, an essential modulator of T cell function \[[@B23]\]; *IL-17ra*, the receptor target for the IL-17 mediated inflammatory pathway \[[@B24]\]; and *Ccl5*(also known as *Rantes*), which regulates the activity of several cellular populations within the immune system \[[@B25]\].

The evidence obtained from the neural transcriptomes (combined with corticosterone and behavioural profiles; van Heerden et al Submitted Manuscript) indicates that pre-weaning treatment (MS or SH) result in differential stress-related profiles. Given this context, the gene expression information derived from the PBMC samples was evaluated in terms of its ability to derive accurate predictions of pre-weaning status of individuals.

PBMC gene expression profiles accurately predict sample classes
---------------------------------------------------------------

The classification and prediction of sample classes (MS or SH) using PBMC gene expression values, were found to be highly efficient. Using KNN (with 4 neighbours), 50 genes (Figure [5](#F5){ref-type="fig"}; Table [1](#T1){ref-type="table"}) were sufficient to accurately identify sample classes 19 out of 20 times. Most of the genes included in the predictor were over-expressed (Figure [5B](#F5){ref-type="fig"}). SVM, however, only achieved this success rate using a minimum of 125 genes (with linear and radial kernels). Importantly, this 125 gene set consisted of the 50 genes included in Table [1](#T1){ref-type="table"}, in addition to 75 other genes, which were the same for both algorithms (data not shown).

###### 

Summary of 50 gene predictor set, which classified samples with 95% accuracy\*

  **Operon Oligo ID**   **Description**                                                              **Symbol**        **ENSEMBL/Refseq/Riken ID**   **Over/Under expressed in MS**
  --------------------- ---------------------------------------------------------------------------- ----------------- ----------------------------- --------------------------------
  M400008627            RIKEN cDNA 4921528I07 gene                                                   *4921528I07Rik*   ENSMUSG00000074149            over
  M200012683            Acetyl-Coenzyme A acetyltransferase 2                                        *Acat2*           ENSMUSG00000023832            over
  M400004596            A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 9   *Adamts9*         ENSMUSG00000030022            over
  M200000582            Adenylate cyclase 8                                                          *Adcy8*           ENSMUSG00000022376            over
  M200005645            Actin related protein 2/3 complex, subunit 5-like                            *Arpc5l*          ENSMUSG00000026755            over
  M200006901            ATPase, H+ transporting, lysosomal V0 subunit E2                             *Atp6v0e2*        ENSMUSG00000039347            over
  M400004024            cDNA sequence BC013672                                                       *BC013672*        ENSMUSG00000037921            over
  M400008030            Bone gamma-carboxyglutamate protein, related sequence 1                      *Bglap-rs1*       ENSMUSG00000074489            over
  M300011602            Carbonic anhydrase 14                                                        *Car14*           ENSMUSG00000038526            over
  M200000995            Cholecystokinins precursor                                                   *Cck*^§^          ENSMUSG00000032532            over
  M200013753            Coronin 7                                                                    *Coro7*           ENSMUSG00000039637            over
  M200003934            Cytochrome P450, family 2, subfamily c, polypeptide 29                       *Cyp2c29*         ENSMUSG00000003053            over
  M300013894            RIKEN cDNA D130054N24 gene                                                   *D130054N24Rik*   ENSMUSG00000042790            over
  M400003995            RIKEN cDNA D330050I23 gene                                                   *D330050I23Rik*   ENSMUSG00000072569            over
  M300010488            Dermokine                                                                    *Dmkn*            ENSMUSG00000060962            over
  M200003607            Dedicator of cytokinesis 7                                                   *Dock7*           ENSMUSG00000028556            over
  M300014949            Endothelial differentiation, sphingolipid G-protein-coupled receptor, 5      *Edg5*            ENSMUSG00000043895            over
  M400001692            Predicted gene                                                               *EG620592*        ENSMUSG00000071719            over
  M400010593            Forkhead box protein R1 (Forkhead box protein N5)                            *Foxr1*           ENSMUSG00000074397            over
  M300000132            Homeo box A4                                                                 *Hoxa4*           ENSMUSG00000000942            over
  M400013298            LSM14 protein homolog A (Rap55)                                              *Lsm14a*          ENSMUSG00000066568            over
  M400004821            Lysocardiolipin acyltransferase                                              *Lycat*           ENSMUSG00000054469            over
  M400009939            Mitogen-activated protein kinase kinase kinase 9                             *Map3k9*          ENSMUSG00000042724            over
  M300007290            Mesoderm posterior 2                                                         *Mesp2*           ENSMUSG00000030543            over
  M200007123            Muted protein                                                                *Muted*^§^        ENSMUSG00000038982            under
  M200010626            Matrix-remodelling associated 8                                              *Mxra8*           ENSMUSG00000073679            over
  M200007448            Nitric oxide synthase interacting protein                                    *Nosip*           ENSMUSG00000003421            over
  M300018063            Olfactory receptor 1495                                                      *Olfr1495*        ENSMUSG00000047207            over
  M300017588            Olfactory receptor 66                                                        *Olfr66*          ENSMUSG00000058200            over
  M300015973            Olfactory receptor 669                                                       *Olfr669*         ENSMUSG00000073916            over
  M300002331            Predicted gene                                                               *MGI:3652048*     ENSMUSG00000020682            over
  M200003458            Oxytocin                                                                     *Oxt*             ENSMUSG00000027301            over
  M400010890            Mus musculus polymerase (RNA) II (DNA directed) polypeptide C                *Polr2c*          ENSMUSG00000031783            over
  M200000936            Peripherin 1                                                                 *Prph1*           ENSMUSG00000023484            over
  M300003403            PTK2 protein tyrosine kinase 2                                               *Ptk2*            ENSMUSG00000022607            under
  M400001722            Slingshot homolog 3 (Drosophila)                                             *Ssh3*            ENSMUSG00000034616            over
  M300003482            Type 2 lactosamine alpha-2,3-sialyltransferase                               *St3gal6*^§^      ENSMUSG00000022747            under
  M200000227            Stromal interaction molecule 1                                               *Stim1*           ENSMUSG00000030987            over
  M300001453            Surfeit gene 5                                                               *Surf5*           ENSMUSG00000015776            over
  M400000616            Thrombopoietin precursor                                                     *Thpo*            ENSMUSG00000022847            over
  M400009774            Transmembrane BAX inhibitor motif containing 1                               *Tmbim1*          ENSMUSG00000006301            over
  M200013582            Transmembrane protein 25                                                     *Tmem25*          ENSMUSG00000002032            over
  M400000938            Transmembrane protein 63A                                                    *Tmem63a*^§^      ENSMUSG00000026519            under
  M400013169            Xin actin-binding repeat containing 2 isoform 2                              *Xirp2*           ENSMUSG00000027022            over
  M400014435            Zinc finger protein 84                                                       *Zfp84*           ENSMUSG00000046185            over
  M400018008            Novel Protein                                                                *Not assigned*    AC160535                      over
  M400012711            Novel protein (I830077J02Rik)                                                *Not assigned*    AC121847                      over
  M400017112            Uncharacterised                                                              *Not assigned*    AK054246                      over
  M400003712            Uncharacterised                                                              *Not assigned*    AC122270                      over
  M400008575            Uncharacterised                                                              *Not assigned*    ENSMUSG00000064159            over

\*Genes are sorted by gene symbol; § Not included in differentially expressed gene list

![**Sample classification and prediction results**. (A) Leave-one-out error rates of classifiers. The KNN algorithm (blue line) reaches an optimal prediction efficiency of 95% with a minimum of 50 genes. Using 125 genes the SVM algorithm (green line) obtains this efficiency, and converges with KNN. (B) Hierarchically sample clustered (Pearson correlation metric with average linkage) profiles for the 50 gene predictor set. Notice, that although only 19 out of 20 samples were correctly classified, hierarchical clustering separates all samples into two general treatment-related clusters. (C) A summary of KNN sample classification results, showing details of the misclassification of individual samples. Although most samples classes were correctly predicted, PBMC69, an SH sample, was consistently misclassified. P = PBMC.](1756-0500-2-195-5){#F5}

Of the 50 genes included in the predictor, 46 were functionally annotated. Of particular interest was the identification of 3 genes, *Oxt*, *Cck*and *Adcy8*(all over-expressed), whose products are known to be important mediators of stress- and anxiety-associated behaviours (Table [1](#T1){ref-type="table"}) \[[@B26]-[@B28]\]. Both Oxt and Cck are neuroactive hormones with previously described endogenous immunomodulatory properties \[[@B29],[@B30]\]. These results confirm that the transcriptional profiles of peripheral immune tissues do indeed contain sufficient information for the efficient diagnostic prediction of stress-related neural states in mice. Products of these genes may participate in pathways that are particularly sensitive to stress-induced regulation of the immune system.
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